Assessment of the Antihyperlipidemic Effect of Garlic Vs Pitavastatin in Patients with Moderate Hyperlipidemia: A Metanalysis of Randomized Controlled Trials

Abstract To assess the efficacy of garlic in comparison with pitavastatin in reducing hypercholesteremia. Databases that include PubMed/Medline, Cochrane, TRIP and SCOPUS were searched. All randomised controlled trials selected for the study. Studies comparing garlic with placebo and pitavastatin with either placebo or other drugs were selected to treat hypercholesteremia. Statistical analysis done using a random-effect model, and results expressed in Mean difference and variance for continuous data with 95% confidence intervals (CI). Twelve studies analysed the efficacy of garlic compared to pitavastatin. Total cholesterol, low-density lipoprotein, high-density lipoprotein, and triglycerides assessed for garlic and pitavastatin's comparative efficacy. Mean difference noticed in total cholesterol in garlic arm was -13.604 with 95% CI = -22.246, -4.962 while in pitavastatin group was -28.205 (95% CI = -29.016,-27.394). The LDL-c reduction not recorded in the garlic arm where the mean increase was recorded of 0.309 (95% CI = -12.502, 13.120) while in the pitavastatin group was -35.538 (95% CI = -39.992, -31.084). Similarly, the increase in HDL was more in the pitavastatin group 5.308 (95% CI = 0.906, 9.710 compared to garlic (2.754 with 95% CI = 1.069, 4.440). Triglycerides level reduction was also low in whereas pitavastatin was -24.210 with 95% CI = -29.249, -19.171.The analysis showed that garlic has a significant effect on lipid profile. The comparison profile of garlic with pitavastatin showed clinical application in the treatment of mild-moderate hypercholesteremia—further studies required the investigator to use the combination therapy in controlled trials. Keywords: Allicin, Allium sativum, Dyslipidemia, Garlic, Hypercholesteremia, Hyperlipidemia Pitavastatin